about
Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary reportSensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosisTract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome.Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency.Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates.Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome.A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease.Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study.Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRIEffect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.Sensitivity and specificity for screening of chronic cerebrospinal venous insufficiency using a multimodal non-invasive imaging approach in patients with multiple sclerosisUse of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects.Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study.Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study.Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study.MRI characteristics of familial and sporadic multiple sclerosis patients.Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study.Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis.Aqueductal cerebrospinal fluid pulsatility in healthy individuals is affected by impaired cerebral venous outflow.Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model.No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis.Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
P50
Q21245254-63A53244-FB7D-4EF2-A064-7E6CE085225FQ28269079-7E6E807C-1B23-4AF9-BD95-30FC77226B32Q30560177-17D1E719-2250-452C-8291-DEC16404DD76Q31039956-5B0E9203-8840-430E-B9D1-5380007A5895Q31047731-EC918B85-2471-4B94-9064-D1B621D05736Q33322308-3E8620FF-C70B-4B34-94C4-7F46EA2E20C5Q33445437-12060FD0-198D-487D-96C4-720951C13D65Q34051741-C44B24E7-CB80-4137-8BE5-524E3F1A31D6Q34343868-ED40CA01-8EDA-492F-8700-7CE77AE0FDA9Q34397786-3542ECE8-E449-4858-897E-895DB48F6464Q34409297-F6971560-95AC-42DC-BD28-AAD3D4B15608Q34493638-8C75E58C-2F51-4ECE-B130-F701B918A72CQ34548374-222ECF87-0982-49B2-8D61-345ADCF9F5BFQ34978091-78E8D2BA-7B64-419C-9A16-85D8826C1C0AQ35119866-74620FBC-978F-4CB8-83B3-4BB7E9224222Q37271609-E5A5DDE6-4C7B-4974-AA5E-0E2C3504456AQ37823008-7250EF99-7CF9-49BF-A850-E3B71DEBFB3FQ39554013-FE76E209-92BD-42F1-816C-BE616257AF6CQ39872443-258394DA-7922-4160-B787-20B7851993D9Q42750410-3D9FF680-0435-4EEC-97C7-E8927FF77954Q43035274-213A9635-6DBD-4235-87EB-F3481AF5EA7EQ43432395-4CFEF327-189A-4334-BF07-871253BF8518Q43580710-4A1C1037-843B-4CE9-9C67-A803E2BC52C6Q43797143-345579C1-8989-4B29-B849-D68CAA5AD1ABQ43806089-106B9C35-424F-4AFD-BECC-92A1BE8AF624Q43946411-3E2B2C26-7717-45C3-A071-44FA21455DCAQ44233459-F441B8EA-51B4-4369-BB36-24B5568C6F75Q44320195-AF1F4CA7-B00B-4E22-AC52-7C5698572C9DQ44486220-FFFDB968-413E-4C40-9E3E-C917948192A6Q44709068-61A32636-49FC-4C42-8F88-C64932B151EBQ44903815-88640CB5-B943-4EBD-8A09-E4654B6DC391Q45305422-28704534-E533-4CCE-93B9-2B4370084D4AQ45998751-766D4286-2BF1-41E7-973A-A58D9ED4E215Q46054853-53989FF6-4FFB-4DE0-AFB2-021425FE370AQ46148199-50BE6279-2998-4BD6-A2E9-22673C5F7C2FQ46309628-AAAF32B9-26A6-4F69-B118-B0EB0B95CFD2Q46466612-CA59F925-E22F-4352-9934-FD3EDEEDC103Q46561361-A1EDCD86-4120-4992-8558-C3F7922DEC8EQ47820950-5BCB1DF5-D476-4D6B-8DD4-EA34D0F74F1AQ47908989-6F04D348-161E-4A64-939E-381C8C48F55B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael G Dwyer
@ast
Michael G Dwyer
@en
Michael G Dwyer
@es
Michael G Dwyer
@nl
Michael G Dwyer
@sl
type
label
Michael G Dwyer
@ast
Michael G Dwyer
@en
Michael G Dwyer
@es
Michael G Dwyer
@nl
Michael G Dwyer
@sl
altLabel
Michael Dwyer
@en
prefLabel
Michael G Dwyer
@ast
Michael G Dwyer
@en
Michael G Dwyer
@es
Michael G Dwyer
@nl
Michael G Dwyer
@sl
P106
P21
P2456
P31
P496
0000-0003-4684-4658